Norvir Antitrust Cases Survive Abbott's Bid To Dismiss

By Ben James

Law360, New York (January 13, 2010, 4:57 PM ET) -- Four suits accusing Abbot Laboratories of illegally jacking up the price for its HIV drug Norvir will remain intact now that a judge has rejected Abbott's motion arguing that the plaintiffs' claims should be thrown out because the drugmaker's actions didn't amount to exclusionary conduct.

Judge Claudia Wilken of the U.S. District Court for the Northern District of California signed off on an order Tuesday denying Abbott's Sept. 10 omnibus motion to dismiss.

Abbott wanted three second amended complaints from direct purchasers — including Safeway Inc.,...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles